MDGL Madrigal Pharmaceuticals, Inc.

NASDAQ
$398.08

Madrigal Pharmaceuticals, Inc. (MDGL) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 1 buyer in the last 30 days 1 buyer in the last 90 days 2 sellers in the last 90 days
Insiders buying
1
5 transactions
Insiders selling
2
25 transactions
Purchases
$35.0M
91,806 shares
Sales
$6.7M
12,660 shares
Net activity
$28.4M
purchases less sales

How much of that selling was preplanned? 49% planned / 51% discretionary

10b5-1 plan sales $3.3M 11 transactions · 6,298 shares
Discretionary sales $3.4M 14 transactions · 6,362 shares

Largest single sale: $837.3K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: November 6, 2026 .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
3 fills Buy 76,140 $384.32 $29.3M 2,040,682
Kelley Shannon T General Counsel Sell 10b5-1 1,077 $400.00 $430.8K 10,397 −9.4% of holding
2 fills Buy 15,666 $367.71 $5.8M 1,964,542
Sibold William John 10 fills President and CEO Sell 10b5-1 5,221 $542.39 $2.8M 202,907 −2.5% of holding
Sibold William John 14 fills President and CEO Sell 6,362 $535.59 $3.4M 209,198 −3% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.